Advanced search
Publication Cover
Journal of Pain & Palliative Care Pharmacotherapy Volume 35, 2021 - Issue 2
Submit an article Journal homepage
376
Views
0
CrossRef citations to date
0
Altmetric
ARTICLE

Substance Abuse Risk and Medication Monitoring in Patients with Advanced Lung Cancer Receiving Palliative Care

Pooja S. KumarPooja S. Kumar, PharmD, and Maureen L. Saphire, PharmD, are with the Department of Pharmacy, The Ohio State University, Columbus, Ohio, USA. Madison Grogan is with the Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA. Jason Benedict, MS, and Sarah Janse, PhD, are with the Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, Ohio, USA. Julia L. Agne, MD, is with the Department of Internal Medicine, Division of Palliative Medicine, The Ohio State University, Columbus, Ohio, USA. Erin M. Bertino, MD, and Carolyn J. Presley, MD, MHS, are with the Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio, USA.View further author information
,
Maureen L. SaphirePooja S. Kumar, PharmD, and Maureen L. Saphire, PharmD, are with the Department of Pharmacy, The Ohio State University, Columbus, Ohio, USA. Madison Grogan is with the Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA. Jason Benedict, MS, and Sarah Janse, PhD, are with the Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, Ohio, USA. Julia L. Agne, MD, is with the Department of Internal Medicine, Division of Palliative Medicine, The Ohio State University, Columbus, Ohio, USA. Erin M. Bertino, MD, and Carolyn J. Presley, MD, MHS, are with the Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio, USA.View further author information
,
Madison GroganPooja S. Kumar, PharmD, and Maureen L. Saphire, PharmD, are with the Department of Pharmacy, The Ohio State University, Columbus, Ohio, USA. Madison Grogan is with the Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA. Jason Benedict, MS, and Sarah Janse, PhD, are with the Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, Ohio, USA. Julia L. Agne, MD, is with the Department of Internal Medicine, Division of Palliative Medicine, The Ohio State University, Columbus, Ohio, USA. Erin M. Bertino, MD, and Carolyn J. Presley, MD, MHS, are with the Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio, USA.View further author information
,
Jason BenedictPooja S. Kumar, PharmD, and Maureen L. Saphire, PharmD, are with the Department of Pharmacy, The Ohio State University, Columbus, Ohio, USA. Madison Grogan is with the Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA. Jason Benedict, MS, and Sarah Janse, PhD, are with the Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, Ohio, USA. Julia L. Agne, MD, is with the Department of Internal Medicine, Division of Palliative Medicine, The Ohio State University, Columbus, Ohio, USA. Erin M. Bertino, MD, and Carolyn J. Presley, MD, MHS, are with the Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio, USA.View further author information
,
Sarah JansePooja S. Kumar, PharmD, and Maureen L. Saphire, PharmD, are with the Department of Pharmacy, The Ohio State University, Columbus, Ohio, USA. Madison Grogan is with the Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA. Jason Benedict, MS, and Sarah Janse, PhD, are with the Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, Ohio, USA. Julia L. Agne, MD, is with the Department of Internal Medicine, Division of Palliative Medicine, The Ohio State University, Columbus, Ohio, USA. Erin M. Bertino, MD, and Carolyn J. Presley, MD, MHS, are with the Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio, USA.View further author information
,
Julia L. AgnePooja S. Kumar, PharmD, and Maureen L. Saphire, PharmD, are with the Department of Pharmacy, The Ohio State University, Columbus, Ohio, USA. Madison Grogan is with the Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA. Jason Benedict, MS, and Sarah Janse, PhD, are with the Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, Ohio, USA. Julia L. Agne, MD, is with the Department of Internal Medicine, Division of Palliative Medicine, The Ohio State University, Columbus, Ohio, USA. Erin M. Bertino, MD, and Carolyn J. Presley, MD, MHS, are with the Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio, USA.View further author information
,
Erin M. BertinoPooja S. Kumar, PharmD, and Maureen L. Saphire, PharmD, are with the Department of Pharmacy, The Ohio State University, Columbus, Ohio, USA. Madison Grogan is with the Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA. Jason Benedict, MS, and Sarah Janse, PhD, are with the Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, Ohio, USA. Julia L. Agne, MD, is with the Department of Internal Medicine, Division of Palliative Medicine, The Ohio State University, Columbus, Ohio, USA. Erin M. Bertino, MD, and Carolyn J. Presley, MD, MHS, are with the Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio, USA.View further author information
&
Carolyn J. PresleyPooja S. Kumar, PharmD, and Maureen L. Saphire, PharmD, are with the Department of Pharmacy, The Ohio State University, Columbus, Ohio, USA. Madison Grogan is with the Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA. Jason Benedict, MS, and Sarah Janse, PhD, are with the Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University, Columbus, Ohio, USA. Julia L. Agne, MD, is with the Department of Internal Medicine, Division of Palliative Medicine, The Ohio State University, Columbus, Ohio, USA. Erin M. Bertino, MD, and Carolyn J. Presley, MD, MHS, are with the Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio, USA.Correspondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2607-5639View further author information
ORCID Icon show all
Pages 91-99 | Received 21 Dec 2020, Accepted 16 Apr 2021, Published online: 19 May 2021

References

  • Rauenzahn S, Sima A, Cassel B, Noreika D, Gomez TH, Ryan L, Wolf CE, Legakis L, Del Fabbro E. Urine drug screen findings among ambulatory oncology patients in a supportive care clinic. Support Care Cancer. 2017;25(6):1859–64. Cited in: PMID: 28120116. doi:10.1007/s00520-017-3575-1.
  • Barclay JS, Owens JE, Blackhall LJ. Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen. Support Care Cancer. 2014;22(7):1883–8. Cited in: PMID: 24563103. doi:10.1007/s00520-014-2167-6.
  • Liebling D, Mehta N, Gulati A. Opioid screening practices in the cancer pain patient. J Palliat Med. 2019;22(1):10–7. doi:10.1089/jpm.2018.0168. Cited in: PMID: 30153080.
  • Carmichael AN, Morgan L, Del Fabbro E. Identifying and assessing the risk of opioid abuse in patients with cancer: an integrative review. Subst Abuse Rehabil. 2016;7:71–9. doi:10.2147/SAR.S85409. Cited in: PMID: 27330340.
  • Tan PD, Barclay JS, Blackhall LJ. Do palliative care clinics screen for substance abuse and diversion? Results of a national survey. J Palliat Med. 2015;18(9):752–7. doi:10.1089/jpm.2015.0098. Cited in: PMID: 26302425.
  • Koyyalagunta D, Bruera E, Aigner C, Nusrat H, Driver L, Novy D. Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF. Pain Med. 2013;14(5):667–75. Cited in: PMID: 23631401. doi:10.1111/pme.12100.
  • Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Validation and clinical application of the screener and opioid assessment for patients with pain (SOAPP). J Pain Symptom Manage. 2006;32(3):287–93. Cited in: PMID: 16939853. doi:10.1016/j.jpainsymman.2006.03.010.
  • Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R). J Pain. 2008;9(4):360–72. Cited in: PMID: 18203666. doi:10.1016/j.jpain.2007.11.014.
  • Butler SF, Budman SH, Fanciullo GJ, Jamison RN. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin J Pain. 2010;26(9):770–6. Cited in: PMID: 20842012. doi:10.1097/AJP.0b013e3181f195ba.
  • Cheatle MD, Compton PA, Dhingra L, Wasser TE, O'Brien CP. Development of the revised opioid risk tool to predict opioid use disorder in patients with chronic nonmalignant pain. J Pain. 2019;20(7):842–51. Cited in: PMID: 30690168. doi:10.1016/j.jpain.2019.01.011.
  • Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432–42. doi:10.1111/j.1526-4637.2005.00072.x.
  • Argoff CE, Alford DP, Fudin J, Adler JA, Bair MJ, Dart RC, Gandolfi R, McCarberg BH, Stanos SP, Gudin JA, et al. Rational urine drug monitoring in patients receiving opioids for chronic pain: consensus recommendations. Pain Med. 2018;19(1):97–117. Cited in: PMID: 29206984. doi:10.1093/pm/pnx285.
  • Mahajan G. Role of urine drug testing in the current opioid epidemic. Anesth Analg. 2017;125(6):2094–104. doi:10.1213/ANE.0000000000002565. Cited in: PMID: 29189366.
  • Sung MR, Patel MV, Djalalov S, Le LW, Shepherd FS, Burkes RL, Feld R, Lin S, Tudor R, Leighl NB. Evolution of symptom burden of advanced lung cancer over a decade. Clin Lung Cancer. 2017;18(3):274–80. Cited in: PMID: 28185791. doi:10.1016/j.cllc.2016.12.010.
  • Simmons CP, Macleod N, Laird BJ. Clinical management of pain in advanced lung cancer. Clin Med Insig Oncol. 2012;6:331–46. doi:10.4137/CMO.S8360. Cited in: PMID: 23115483.
  • Hall OT, Hall OE, McGrath RP, Haile ZT. Years of life lost due to opioid overdose in Ohio: temporal and geographic patterns of excess mortality. J Addict Med. 2020;14(2):156–62. doi:10.1097/ADM.0000000000000554. Cited in: PMID: 31592905.
  • Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths: United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419–27. doi:10.15585/mmwr.mm675152e1. Cited in: PMID: 30605448.
  • Arthur JA. Urine drug testing in cancer pain management. Oncologist. 2020;25(2):99–104. doi:10.1634/theoncologist.2019-0525. Cited in: PMID: 32043770.
  • NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain (version 1.2018). Plymouth Meeting, PA: National Comprehensive Cancer Network; 2018.
  • Einstein DJ, DeSanto-Madeya S, Gregas M, Lynch J, McDermott DF, Buss MK. Improving end-of-life care: palliative care embedded in an oncology clinic specializing in targeted and immune-based therapies. JOP. 2017;13(9):e729–37. Cited in: PMID: 28562197. doi:10.1200/JOP.2016.020396.
  • Walling AM, D'Ambruoso SF, Malin JL, Hurvitz S, Zisser A, Coscarelli A, Clarke R, Hackbarth A, Pietras C, Watts F, et al. Effect and efficiency of an embedded palliative care nurse practitioner in an oncology clinic. J Oncol Pract. 2017;13(9):e792–9. doi:10.1200/JOP.2017.020990. Cited in: PMID: 28813191.
  • Yennurajalingam S, Edwards T, Arthur JA, Lu Z, Najera J, Nguyen K, Manju J, Kuriakose L, Wu J, Liu D, et al. Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center. Cancer. 2018;124 (19):3942–9. Cited in: PMID: 30192372. doi:10.1002/cncr.31670.
  • Passik SD, Kirsh KL, Donaghy KB, Portenoy RK. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain. 2006;22(2):173–81. Cited in: PMID: 16428952. doi:10.1097/01.ajp.0000161525.48245.aa.
  • Paice JA. Risk assessment and monitoring of patients with cancer receiving opioid therapy. Oncologist. 2019; 24(10):1294–8. doi:10.1634/theoncologist.2019-0301. Cited in: PMID: 31118217.
  • Reyes-Gibby CC, Anderson KO, Todd KH. Risk for Opioid misuse among emergency department cancer patients. Acad Emerg Med. 2016;23(2):151–8. doi:10.1111/acem.12861. Cited in: PMID: 26824227.
  • Yasin JT, Leader AE, Petok A, Garber G, Stephens B, Worster B. Validity of the screener and opioid assessment for patients with pain-revised (SOAPP-R) in patients with cancer. J Opioid Manag. 2019;15(4):272–4. doi:10.5055/jom.2019.0512. Cited in: PMID: 31637679.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.